The FDA wants to pull its approval of a drug. It’s not so easy.

The FDA wants to pull its approval of a drug. It’s not so easy.

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

arstechnica.com/science/2026/10/the-fda-wants-to-pull-its-approval-of-a-drug-its-not-so-easy/